Note: This document contains side effect information about morphine liposomal. Some dosage forms listed on this page may not apply to the brand name DepoDur.
Applies to morphine liposomal: injectable suspension extended release.
General
The more commonly reported side effects have included nausea, pruritus, pyrexia, vomiting, hypotension, anemia, headache, constipation, decreased oxygen saturation, urinary retention, and dizziness.[Ref]
Respiratory
Very common (10% or more): Decreased oxygen saturation
Common (1% to 10%): Hypoxia, respiratory depression, hypercapnia, dyspnea
Postmarketing reports: Severe respiratory depression, involving apnea or respiratory arrest, and cardiac arrest[Ref]
Prolonged and serious respiratory depression was reported when administration was associated with subarachnoid puncture. In these cases, respiratory depression occurred following apparent recovery from anesthesia (within 12 hours of administration).
Four percent of patients receiving this drug in clinical trials required treatment with narcotic antagonists for respiratory depression; 90% of respiratory depression events were reported within the first 24 hours. Delayed respiratory depression (occurring up to 48 hours postdose) was reported in 2% of patients; 0.6% of patients reported respiratory depression after more than 48 hours. During the postmarketing period, severe respiratory depression involving apnea or respiratory arrest have been reported following administration of labeled doses.[Ref]
Nervous system
Postmarketing reports: Central nervous system depression, including obtunded feeling, non-arousable condition, unresponsiveness, confusion, and lethargy[Ref]
CNS depression, including obtunded feeling, non-arousable condition, unresponsiveness, confusion, and lethargy, has been reported. In most cases, there was concomitant administration of different narcotics or hypnotic/sedative medications in the post-operative period.[Ref]
Cardiovascular
Very common (10% or more): Hypotension
Common (1% to 10%): Tachycardia, hypertension, bradycardia[Ref]
Gastrointestinal
Very common (10% or more): Vomiting, constipation, nausea
Common (1% to 10%): Flatulence, paralytic ileus, dyspepsia, abdominal distension[Ref]
Dermatologic
Very common (10% or more): Pruritus
Common (1% to 10%): Hypoesthesia, increased sweating[Ref]
Musculoskeletal
Common (1% to 10%): Rigors[Ref]
Metabolic
Common (1% to 10%): Hypokalemia
Psychiatric
Common (1% to 10%): Anxiety
Hematologic
Very common (10% or more): Anemia
Common (1% to 10%): Decreased hematocrit[Ref]
Genitourinary
Very common (10% or more): Urinary retention
Common (1% to 10%): Bladder spasm, oliguria[Ref]